PharmacyCodes



Bitolterolum [INN-Latin] en es it fr

Bitolterolum [INN-Latin] Brand names, Bitolterolum [INN-Latin] Analogs

Bitolterolum [INN-Latin] Brand Names Mixture

  • No information avaliable

Bitolterolum [INN-Latin] Chemical_Formula

C28H31NO5

Bitolterolum [INN-Latin] RX_link

No information avaliable

Bitolterolum [INN-Latin] fda sheet

Bitolterolum [INN-Latin] msds (material safety sheet)

Bitolterolum [INN-Latin] Synthesis Reference

No information avaliable

Bitolterolum [INN-Latin] Molecular Weight

461.549 g/mol

Bitolterolum [INN-Latin] Melting Point

No information avaliable

Bitolterolum [INN-Latin] H2O Solubility

No information avaliable

Bitolterolum [INN-Latin] State

Solid

Bitolterolum [INN-Latin] LogP

5.923

Bitolterolum [INN-Latin] Dosage Forms

Metered dose inhaler in 16.4 grams (15mL) and a 10mL dropper bottles containing 0.2% solution for hand held nebulizer.

Bitolterolum [INN-Latin] Indication

Used to dilate air passages in the lungs that have become narrowed as a result of disease or inflammation. It is used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Bitolterolum [INN-Latin] Pharmacology

Bitolterol, an adrenergic bronchodilator, is a prodrug that widens constricted airways in the lungs by relaxing the smooth muscles that surround the bronchial passages. Bitolterol probably does not affect the inflammation in the lung, such as in bronchitis. Bitolterol is unique in that it is a prodrug because it must first be metabolized by the body before it becomes active.

Bitolterolum [INN-Latin] Absorption

No information avaliable

Bitolterolum [INN-Latin] side effects and Toxicity

No information avaliable

Bitolterolum [INN-Latin] Patient Information

Bitolterolum [INN-Latin] Organisms Affected

Humans and other mammals